Norges Bank
BHVN

Norges Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Norges Bank’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-633,780
Closed -$95.8M – 2222
2022
Q3 		$95.8M Buy
633,780
+29,701
+5% +$4.4M 0.03% 523
2022
Q2 		$88M Buy
604,079
+121,864
+25% +$15.6M 0.02% 564
2022
Q1 		$57.2M Buy
482,215
+79,483
+20% +$9.91M 0.01% 805
2021
Q4 		$55.5M Buy
402,732
+9,823
+3% +$1.25M 0.01% 884
2021
Q3 		$54.6M Sell
392,909
-21,514
-5% -$2.69M 0.01% 873
2021
Q2 		$40.2M Buy
414,423
+16,484
+4% +$1.34M 0.01% 1097
2021
Q1 		$27.2M Sell
397,939
-109,699
-22% -$8.87M 0.01% 1348
2020
Q4 		$43.5M Buy
507,638
+19,370
+4% +$1.64M 0.01% 1074
2020
Q3 		$31.7M Sell
488,268
-25,237
-5% -$1.65M 0.01% 1124
2020
Q2 		$37.5M Buy
513,505
+7,135
+1% +$380K 0.01% 1038
2020
Q1 		$17.2M Buy
506,370
+25,949
+5% +$1.19M 0.01% 1345
2019
Q4 		$26.2M Buy
480,421
+29,618
+7% +$1.47M 0.01% 1375
2019
Q3 		$18.8M Hold
450,803
– – 0.01% 1514
2019
Q2 		$19.7M Buy
450,803
+333,293
+284% +$18.8M 0.01% 1513
2019
Q1 		$6.05M Buy
+117,510
New +$5.08M ﹤0.01% 1916
2018
Q1 		– Sell
-50,000
Closed -$1.35M – 2204
2017
Q4 		$1.35M Hold
50,000
– – ﹤0.01% 2023
2017
Q3 		$1.87M Hold
50,000
– – ﹤0.01% 1976
2017
Q2 		$1.25M Buy
+50,000
New +$1.15M ﹤0.01% 2023

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Norges Bank's BHVN Position: Q4 2022 in Review

Norges Bank sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 633,780 shares — an estimated $95.8M sold.

Norges Bank first reported a position in BHVN in Q2 2017 and held it in 18 quarters. The position peaked at $95.8M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Norges Bank reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Norges Bank sold 633,780 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $95.8M.
  • Norges Bank first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 18 quarters.
  • Norges Bank's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $95.8M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Norges Bank's 13F filing for Q4 2022, filed 14 Feb 2023.